Cytokinetics, Inc. (CYTK)
75.85
-2.79
(-3.55%)
USD |
NASDAQ |
May 15, 16:00
75.83
-0.02
(-0.03%)
After-Hours: 20:00
Cytokinetics Market Cap : 10.30B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 116.40B |
| Regeneron Pharmaceuticals, Inc. | 73.20B |
| Sarepta Therapeutics, Inc. | 1.853B |
| Moderna, Inc. | 19.46B |
| Revolution Medicines, Inc. | 30.97B |
Market Cap Related Metrics
| PS Ratio | 86.94 |
| PEG Ratio | -0.3836 |
| Price | 75.85 |
| Earnings Yield | -9.02% |
| PEGY Ratio | -0.3836 |